REFERENCES
- Chiong, W., M. K. Leonard, and E. F. Chang. 2018. Neurosurgical patients as human research subjects: Ethical considerations in intracranial electrophysiology research. Neurosurgery 83(1): 29–37. doi: 10.1093/neuros/nyx361.
- Gilbert, F., and E. Goddard. 2014. Thinking ahead too much: Speculative ethics and implantable brain devices. AJOB Neuroscience 5(1): 49–51. doi: 10.1080/21507740.2013.863252.
- Glannon, W. 2010. Consent to deep brain stimulation for neurological and psychiatric disorders. The Journal of Clinical Ethics 21(2): 104–111.
- Lawrence, R. E., C. R. Kaufmann, R. B. DeSilva, and P. Appelbaum. 2019. Patients’ beliefs about deep brain stimulation for treatment-resistant depression. American Journal of Bioethics, Neuroscience 9(4): 210–218.
- Lázaro-Muñoz, G. 2017. Responsible translation of psychiatric genetics and other neuroscience developments: In need of empirical bioethics research. The American Journal of Bioethics 17(4): 33–35. doi: 10.1080/15265161.2017.1284917.
- Lucke, J. C., S. Bell, B. Partridge, and W. D. Hall. 2011. Deflating the neuroenhancement bubble. AJOB Neuroscience 2(4): 38–43. doi: 10.1080/21507740.2011.611122.
- Mathers, J., C. Rick, C. Jenkinson, et al. 2016. Patients’ experiences of deep brain stimulation for parkinson’s disease: A qualitative systematic review and synthesis. BMJ Open 6(6): e011525. doi: 10.1136/bmjopen-2016-011525.
- Neuroforensics. 2018. Exploring the legal implications of emerging neurotechnologies: Proceedings of a workshop. https://www.nap.edu/catalog/25150/neuroforensics-exploring-the-legal-implications-of-emerging-neurotechnologies-proceedings-of (accessed Nov 1, 2018).
- Nordmann, A. 2007. If and then: A critique of speculative nanoethics. Nanoethics 1(1): 31–46. doi: 10.1007/s11569-007-0007-6.
- Outram, S. M. 2010. The use of methylphenidate among students: The future of enhancement? Journal of Medical Ethics 36(4): 198–202. doi: 10.1136/jme.2009.034421.